Clinical Edge Journal Scan

Low disease activity tied to increased bone mineral density in RA


 

Key clinical point: In patients with rheumatoid arthritis (RA), low cumulative disease activity was associated with an increased femoral neck bone mineral density (BMD), irrespective of established osteoporosis risk factors.

Major finding: Low cumulative disease activity as measured by Disease Activity Score in 28 Joints with erythrocyte sedimentation rate was independently associated with higher femoral neck BMD compared with moderate/high disease activity (β 0.071; P = .020).

Study details: The findings come from an observational cohort study involving 161 patients with RA.

Disclosures: This study was funded by the Rheumatology Research Foundation Scientist Development Award, National Institute of Aging, and others. The authors declared no conflicts of interest.

Source: Wysham KD et al. Semin Arthritis Rheum. 2022;53:151972 (Jan 31). Doi: 10.1016/j.semarthrit.2022.151972

Recommended Reading

Dietary recommendations for inflammatory rheumatic diseases
MDedge Rheumatology
Patients are interrupting DMARD use well into the COVID-19 pandemic
MDedge Rheumatology
Treat-to-target in RA: Questions remain about adoption, measurement
MDedge Rheumatology
Rheumatoid arthritis: Higher risk for MACE and cancer with tofacitinib vs. TNF inhibitors
MDedge Rheumatology
More evidence supporting ultra-low retreatment dose of rituximab in RA
MDedge Rheumatology
Acute exacerbation affects prognosis in RA-associated interstitial lung disease
MDedge Rheumatology
A real-world analysis finds no evidence of increased CV risk with tofacitinib vs. TNFi in RA
MDedge Rheumatology
Early RA: Prevalence and factors associated with methotrexate-related adverse events
MDedge Rheumatology
A healthy lifestyle may prevent the development of RA
MDedge Rheumatology
DMARDs or corticosteroids use may not explain reduced risk for Parkinson disease in RA
MDedge Rheumatology